SCHEMBL5772655

SCHEMBL5772655

O=C(c1ccccc1)n1nc(CCCN2CCN(c3ccc(F)cc3)CC2)c2c1CCCC2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 6/20 0.51
DRD4 P21917 5/20 0.48
SLC6A4 P31645 2/20 0.48
HTR2A P28223 7/20 0.47
DRD2 P14416 6/20 0.47
DRD3 P35462 5/20 0.46
HTR7 P34969 2/20 0.46
PARP1 P09874 2/20 0.45
HTR2C P28335 3/20 0.45
HRH1 P35367 3/20 0.45
TMEM97 Q5BJF2 2/20 0.45
SIGMAR1 Q99720 2/20 0.45
CHRM1 P11229 1/20 0.45
DRD1 P21728 1/20 0.45
HTR2B P41595 1/20 0.45
HTR6 P50406 1/20 0.45
SLC6A3 Q01959 1/20 0.45
GRIN1 Q05586 1/20 0.43
GRIN2B Q13224 1/20 0.43
ABCB1 P08183 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5776218 0.86 DRD4 (0.49) HTR1ADRD4SLC6A4HTR2ADRD2
SCHEMBL5770572 0.84 HTR1A (0.50) HTR1ADRD4SLC6A4HTR2ADRD2
SCHEMBL7959679 0.82 DRD3 (0.49) HTR1ADRD4SLC6A4HTR2ADRD2
SCHEMBL7959986 0.80 HTR1A (0.51) HTR1ADRD4SLC6A4HTR2ADRD2
SCHEMBL7963930 0.75 SIGMAR1 (0.53) HTR1ADRD4HTR2ADRD2DRD3
SCHEMBL7959137 0.75 SIGMAR1 (0.53) HTR1ADRD4HTR2ADRD2DRD3
Maleic Acid SCHEMBL7959572 0.72 SIGMAR1 (0.49) HTR1ADRD4SLC6A4HTR2ADRD2
Fumaric Acid SCHEMBL7959573 0.72 SIGMAR1 (0.49) HTR1ADRD4SLC6A4HTR2ADRD2
SCHEMBL7963943 0.72 MAPT (0.50) HTR1AHTR7SIGMAR1SLC6A3
SCHEMBL5771935 0.72 DRD4 (0.46) HTR1ADRD4SLC6A4HTR2ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885883-B1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF MITSUBISHI PHARMA CORP (JP) 2006-11-02 EP disclosed
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed